Entradas por csanchez

Rev Esp Quimioter 2010:23(4):177-183

Prophylaxis and treatment of invasive fungal infection in neutropenic patients  C. VALLEJO, M. ROVIRA      Prophylaxis and treatment constitute the basis for reducing the mortality due to IFI. Prophylaxis is currently the standard practice in most hospitals and is recommended by the principal guidelines. Fluconazole has proved to be useful to prevent and reduce the mortality […]

Rev Esp Quimioter 2010:23(4):169-176

Antifungal agents in the treatment of systemic infections: Relevance of mechanism of action, activity profile and resistances  M. CUENCA-ESTRELLA      The availability of different therapeutic alternatives has modified the treatment of systemic fungal infections. There commendations of antifungal therapy vary according to species which causes the mycosis and its susceptibility. Consequently, the knowledge of action […]

Rev Esp Quimioter 2010:23(4):158-168

Nosocomial candidemia: new challenges of an emergent problem  J. GÓMEZ, E. GARCÍA-VAZQUEZ, A. HERNÁNDEZ, C. ESPINOSA, J. RUIZ GÓMEZ      Candida spp. are currently one of the most common causes of bloodstream infections in hospitals. Over the last two decades there has been a shift towards a greater involvement of non-Candida albicans as the cause of […]

Rev Esp Quimioter 2010:23(3):144-152

Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study  C. GIMENO, R. CANTÓN, A. GARCÍA, M. GOBERNADO Y GRUPO ESPAÑOL DE ESTUDIO DE DORIPENEM      Introduction. Doripenem is a new carbapenem with broad spectrum antibacterial activity indicated for the treatment of nosocomial pneumonia and complicated urinary […]

Rev Esp Quimioter 2010:23(3):135-143

Impact factor and quality of scientific publications on Microbiology: the example of the Spanish Journal of Chemotherapy  D. CARABANTES      Introduction. The impact factor of a journal is the quantitative analysis of the number of citations obtained during a specific period of time. This currently is the standard tool to measure the quality of the […]

Rev Esp Quimioter 2010:23(3):126-134

Critical study of spanish adult consumer profile of antibiotics on the basis of National Surveys of Health in 1993, 1995, 1997, 2001 and 2003  J. L. BAQUERO, J. BARBERÁN, D.MARTÍNEZ      Objective: The objective of this study has been to examine antibiotic consumption in Spain through the use of the National Surveys of Health (NSH) […]

Rev Esp Quimioter 2010:23(3):122-125

Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates  A. J. CARRILLO-MUÑOZ, C. TUR-TUR, J. M. HERNÁNDEZ-MOLINA, G. QUINDÓS, C. MARCOS-ARIAS, E. ERASO, D. CÁRDENES, O. ORTIZ-MAESTRO, P. SANTOS, D. ESTIVILL, C. GUARDIA, G. GIUSIANO    The in vitro antifungal activity of posaconazole was tested against 315 yeast clinical isolates and 11 […]

Rev Esp Quimioter 2010:23(3):115-121

Endotoxin adsortion as adjuvant therapy in gramnegative severe sepsis  F.J. CANDEL, F. MARTÍNEZ-SAGASTI, M. BORGES, E. MASEDA, M. HERRERA-GUTIÉRREZ, J. GARNACHO-MONTERO, F.J. MAYNAR, R. ZARAGOZA, J. MENSA, J.R. AZANZA    The mortality rate of severe sepsis and septic shock remains still high. Within the last years a better knowledge of its physiopathology and the implementation […]

Rev Esp Quimioter 2010:23(3):109-114

Treatment of human infections caused by Bartonella spp.  L. PÉREZ-MARTÍNEZ, J. R. BLANCO, J. A. OTEO    Infections by Bartonella spp. include a wide spectrum of emerging and re-emerging infectious diseases.There is not a universal therapy for this infection, therefore treatment should be chosen individually. The aim of this review is to update the therapeutics […]

Rev Esp Quimioter 2010:23(2):103-108

A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects   F.J. CANDEL, N. CALVO, J. HEAD, A. SÁNCHEZ, M. MATESANZ, E. CULEBRAS, A. BARRIENTOS, J. PICAZO    Acinetobacter baumannii are emerging as the causal agents of healthcare-associated infections. We describe a renal transplant recipient […]